RHT HealthTrust   

Future Indian IPOs affected on Religare slump?

From their slides : http://rhtrust.listedcompany.com/newsroom/rht121113ppt.pdf


  Cumulative Distribution
Amount: 4.05 cents
Ex-date: 25 Nov 2013
Payment Date: 16 Dec 2013

 

Huat ah...




Vested

 

Giving out dividend 0.0405
Until which date need to keep the stock to entitle for the dividend?
25th or 27th?

 

Wow my prediction came true ..Relicare dropped < 90cts...I was lucky to sell of Ascendas H.T after ex dpu..if not suffer losses liao..bros got hope cut yr losses ,with this $$$ can buy Rowsley at 57cts and maybe sell off when they push to .67cts before it goes xall...likely will happen ..typical of Peter Lim..like on Monday 2 Sept I cut my Aspial at 41,5cts..I bgt at 43 cts but prevuously received the rights at 38cts and interim dividends..marginal loss ..I bought 48cts of Rowsley at 100lots at 4.15pm by 5pm close Rowsley was 55cts ,more than recovered everything..I know not easy to cut loss,but it is worth it if yr stock not moving ,it's better to switch to potential 'flying" pennies...even if stuck,u hve 2 free warrants for every 1 shares..trust me can still make..becoz i hve seen how P.L worked since he was in Kayhian when he was still remisier..just my suggestion only..hope u make $$$ but don't blame me if don't make...shd make $$$ lah

starlene      ( Date: 22-May-2013 16:32) Posted: May drop back to 90cts or below after ex dpu..just like ascendas HT crossed $1 then after dpu now 97cts..I reckon   this counter difficult to cross $1 as its dpu and profit slightly below ipo's forecast guoyanyunyan      ( Date: 22-May-2013 11:54) Posted: Religare Health Trust  registered a DPU of 3.55 cents for the period spanning Oct 19, 2012, to March 31, 2013. Revenue achieved exceeded expectations, at $49.6mil, which was mainly due to the strong performance of the hospital income segment, driven by higher occupancy rates at Religare's two operating hospitals. Religare, a unit of India's Fortis Healthcare, has 11 Religare clinical establishments, four greenfi eld clinical establishments and two operating hospitals through‐ out India, which were valued at about $748mil as at end‐ March. Religare's gearing stands at 9%, with total borrowings of $65.3mil. NAV of its portfolio has grown to $714mil as at end‐ March.   ...Last Done: $0.975...

 

This stock worth to buy ? Or this stock must sell and buy other reit instead?

guoyanyunyan      ( Date: 25-Jun-2013 14:14) Posted: Religare Health Trust - Eyeing acquisitions .... Target S$1.07 (Long Term: Out Perform) RHT joined us at our recent Asia-Pacific Conference. Listed last year, it has delivered well on forecasts and is ramping up operations at Gurgaon Hospital. Forward yields after its recent selldown are 9-10% with growth supplemented by ARPOB and capacity expansion. We keep our DPU estimates and DDM-based target price (discount rate: 11.7%). Maintain Outperform with attractive headline yields, earnings deliveries and acquisitions as catalysts. We keep our DPU estimates and DDM-based target price (discount rate: 11.7%). Maintain Outperform with attractive headline yields, earnings deliveries and acquisitions as catalysts. What Happened CEO, Mr Gurpreet Dhillon, and CFO, Mr Pawanpreet, participated in our recent annual Asia-Pacific Conference. As RHT was just listed last year, its meetings were mainly introductory. Discussions centred on: 1) forex fluctuations / hedges 2) acquisitions and 3) growth of its underlying assets. Management says the trust's forex exposure has been fully hedged till Mar 15 with a policy of hedging distributions for the next 12 months on a rolling basis. Management is evaluating three potential assets (estimated value of S$100m) for acquisition. Assets under consideration are those which are operated by Fortis but owned by third parties. As for underlying assets, revenue growth for its seven largest assets was 7-55% yoy in FY3/13. What We Think RHT offers a combination of stability through its fixed base fees (that are growing 3% p.a.) and growth through variable fees tied to the revenue growth of its underlying assets. The latter should come from capacity expansion and ARPOB increases for underlying assets. Meanwhile, RHT's low asset leverage should provide debt headroom for acquisition growth while parent/sponsor's deleveraging efforts should instil some confidence. What You Should Do Share price has corrected alongside a weakening Indian rupee and the broad-based selldown of SREITs and other yield instruments in the wake bond yield spikes. Maintain Outperform, nonetheless, as we believe attractive headline yields of 9-10% have priced in some risks. We see re-rating catalysts from earnings deliveries and acquisitions.      ...Last Done: $0.84...

 

Religare Health Trust - Eyeing acquisitions ....

Target S$1.07 (Long Term: Out Perform)

RHT joined us at our recent Asia-Pacific Conference. Listed last year, it has delivered well on forecasts and is ramping up operations at Gurgaon Hospital. Forward yields after its recent selldown are 9-10% with growth supplemented by ARPOB and capacity expansion. We keep our DPU estimates and DDM-based target price (discount rate: 11.7%). Maintain Outperform with attractive headline yields, earnings deliveries and acquisitions as catalysts.

We keep our DPU estimates and DDM-based target price (discount rate: 11.7%). Maintain Outperform with attractive headline yields, earnings deliveries and acquisitions as catalysts.

What Happened
CEO, Mr Gurpreet Dhillon, and CFO, Mr Pawanpreet, participated in our recent annual Asia-Pacific Conference. As RHT was just listed last year, its meetings were mainly introductory. Discussions centred on: 1) forex fluctuations / hedges 2) acquisitions and 3) growth of its underlying assets.

Management says the trust's forex exposure has been fully hedged till Mar 15 with a policy of hedging distributions for the next 12 months on a rolling basis. Management is evaluating three potential assets (estimated value of S$100m) for acquisition. Assets under consideration are those which are operated by Fortis but owned by third parties. As for underlying assets, revenue growth for its seven largest assets was 7-55% yoy in FY3/13.

What We Think
RHT offers a combination of stability through its fixed base fees (that are growing 3% p.a.) and growth through variable fees tied to the revenue growth of its underlying assets. The latter should come from capacity expansion and ARPOB increases for underlying assets. Meanwhile, RHT's low asset leverage should provide debt headroom for acquisition growth while parent/sponsor's deleveraging efforts should instil some confidence.

What You Should Do
Share price has corrected alongside a weakening Indian rupee and the broad-based selldown of SREITs and other yield instruments in the wake bond yield spikes. Maintain Outperform, nonetheless, as we believe attractive headline yields of 9-10% have priced in some risks. We see re-rating catalysts from earnings deliveries and acquisitions.      ...Last Done: $0.84...

 

...Married Deal:  Vol: 594  Value: $529,150  ie $0.891/share  Prev Close: $0.890...

 

3 lots of Religare can buy a piece of land in India.   Those from the home country sure to sell.   Hard for the counter to go far. Rather sell earlier everything in exchange for Yangzijiang with some extra changes to keep and good chances to gain on portfolio.. Wahahah!!

starlene      ( Date: 22-May-2013 16:32) Posted: May drop back to 90cts or below after ex dpu..just like ascendas HT crossed $1 then after dpu now 97cts..I reckon   this counter difficult to cross $1 as its dpu and profit slightly below ipo's forecast guoyanyunyan      ( Date: 22-May-2013 11:54) Posted: Religare Health Trust  registered a DPU of 3.55 cents for the period spanning Oct 19, 2012, to March 31, 2013. Revenue achieved exceeded expectations, at $49.6mil, which was mainly due to the strong performance of the hospital income segment, driven by higher occupancy rates at Religare's two operating hospitals. Religare, a unit of India's Fortis Healthcare, has 11 Religare clinical establishments, four greenfi eld clinical establishments and two operating hospitals through‐ out India, which were valued at about $748mil as at end‐ March. Religare's gearing stands at 9%, with total borrowings of $65.3mil. NAV of its portfolio has grown to $714mil as at end‐ March.   ...Last Done: $0.975...

 

May drop back to 90cts or below after ex dpu..just like ascendas HT crossed $1 then after dpu now 97cts..I reckon   this counter difficult to cross $1 as its dpu and profit slightly below ipo's forecast

guoyanyunyan      ( Date: 22-May-2013 11:54) Posted: Religare Health Trust  registered a DPU of 3.55 cents for the period spanning Oct 19, 2012, to March 31, 2013. Revenue achieved exceeded expectations, at $49.6mil, which was mainly due to the strong performance of the hospital income segment, driven by higher occupancy rates at Religare's two operating hospitals. Religare, a unit of India's Fortis Healthcare, has 11 Religare clinical establishments, four greenfi eld clinical establishments and two operating hospitals through‐ out India, which were valued at about $748mil as at end‐ March. Religare's gearing stands at 9%, with total borrowings of $65.3mil. NAV of its portfolio has grown to $714mil as at end‐ March.   ...Last Done: $0.975...

 

Religare Health Trust  registered a DPU of 3.55 cents for the period spanning Oct 19, 2012, to March 31, 2013. Revenue achieved exceeded expectations, at $49.6mil, which was mainly due to the strong performance of the hospital income segment, driven by higher occupancy rates at Religare's two operating hospitals. Religare, a unit of India's Fortis Healthcare, has 11 Religare clinical establishments, four greenfi eld clinical establishments and two operating hospitals through‐ out India, which were valued at about $748mil as at end‐ March. Religare's gearing stands at 9%, with total borrowings of $65.3mil. NAV of its portfolio has grown to $714mil as at end‐ March.   ...Last Done: $0.975...

 

You are right! Hati-hati!小 心 ！

New123      ( Date: 03-Jan-2013 14:42) Posted: first few  day of ipo the price tumble to 77 cents. they buy back and then sell for 2nd round of big profit.. be careful dont be trapped .. starlene      ( Date: 03-Jan-2013 13:26) Posted: One of the directors Michael Huang bought cheap to support the shares from slumping when first listed and now selling 88-898.5cts

 

Religare back to IPO price of 90 cents.   With today's IPO of Logistic, quite good showing, Religare should receive courage and make it a happy occasion for vested shareholders.   Go man go.   Make a concerted effort to go above $1.00. Strike when the iron is hot! (Meaning with good market sentiments, don't waste it.) Huat arghhhh..

 

Facebook trying a comeback recently. Religare showing good support above 88 cents.

Tomique      ( Date: 30-Oct-2012 09:18) Posted: Obviously it was the work of short sellers like Facebook that was shorted even before it was listed.   Might happen here too.

 

Since few people have this after its poor IPO, it may make a surprise visit abv 90cents and then beyond to probably 95 or above 1.00 because sentiment is different from the time of IPO.   Can try a few, hahaha.

 

first few  day of ipo the price tumble to 77 cents. they buy back and then sell for 2nd round of big profit.. be careful dont be trapped ..

starlene      ( Date: 03-Jan-2013 13:26) Posted: One of the directors Michael Huang bought cheap to support the shares from slumping when first listed and now selling 88-898.5cts

 

director buy --> good

director sell --> no good

? 

 

One of the directors Michael Huang bought cheap to support the shares from slumping when first listed and now selling 88-898.5cts

 

This one is moving up to test the IPO price of 90 cents soon. Anybody buying?

 

1	2012-10-31	---	RELIGARE HEALTH TRUST	Mitsubishi UFJ Financial Group, Inc.	Substantial Shareholder	Buy	---	1681999	---
2	2012-10-31	---	RELIGARE HEALTH TRUST	(1) Morgan Stanley and (2) Mo...	Substantial Shareholder	Buy	---	1681999	---
3	2012-10-30	---	RELIGARE HEALTH TRUST	Mitsubishi UFJ Financial Group, Inc.	Substantial Shareholder	Sell	---	2509250	---
4	2012-10-30	2012-10-29	RELIGARE HEALTH TRUST	Hwang Sydney Michael	Director	Buy	Open Market Purchase	200000	0.80

 

1	2012-10-29	---	RELIGARE HEALTH TRUST	(1) Morgan Stanley and (2) an...	Substantial Shareholder	Sell	---	2509250	---
2	2012-10-25	2012-10-24	RELIGARE HEALTH TRUST	Hwang Sydney Michael	Director	Buy	Open Market Purchase	100000	0.80
3	2012-10-24	2012-10-19	RELIGARE HEALTH TRUST	Mitsubishi UFJ Financial Group, Inc.	Substantial Shareholder	Buy	# Others	40582250	0.88
4	2012-10-24	2012-10-19	RELIGARE HEALTH TRUST	Morgan Stanley International H...	Substantial Shareholder	Buy	# Others	40582250	0.88
5	2012-10-24	2012-10-19	RELIGARE HEALTH TRUST	Morgan Stanley	Substantial Shareholder	Buy	# Others	40582250	0.88
6	2012-10-24	2012-10-19	RELIGARE HEALTH TRUST	Henderson Global Investors Ltd	Substantial Shareholder	Buy	# Others	30000000	0.90
7	2012-10-24	---	RELIGARE HEALTH TRUST	Malvinder Mohan Singh	Substantial Shareholder	Buy	Open Market Purchase	500000	---
8	2012-10-24	---	RELIGARE HEALTH TRUST	Malvinder Mohan Singh	Substantial Shareholder	Buy	---	3500000	---
9	2012-10-24	2012-10-22	RELIGARE HEALTH TRUST	Ravi Mehrotra	Director	Buy	Open Market Purchase	1000000	0.8088
10	2012-10-23	2012-10-22	RELIGARE HEALTH TRUST	Hwang Sydney Michael	Director	Buy	Open Market Purchase	200000	0.77
11	2012-10-23	2012-10-22	RELIGARE HEALTH TRUST	Gurpreet Singh Dhillon	Director	Buy	Open Market Purchase	300000	0.775
12	2012-10-22	2012-10-19	RELIGARE HEALTH TRUST	Hwang Sydney Michael	Director	Buy	Open Market Purchase	500000	0.89
13	2012-10-22	2012-10-19	RELIGARE HEALTH TRUST	Deepak Manoharlal Chhabria	Director	Buy	# Others	700000	0.90
14	2012-10-22	2012-10-19	RELIGARE HEALTH TRUST	Gurpreet Singh Dhillon	Director	Buy	# Others	937000	0.90

 

Obviously it was the work of short sellers like Facebook that was shorted even before it was listed.   Might happen here too.